Establishment of a Prognostic Prediction and Drug Selection Model for Patients with Clear Cell Renal Cell Carcinoma by Multiomics Data Analysis

<div>Verification in external dataset. (a) Heatmap of NTP in outer KIRC cohort using subtype-specific upregulated biomarkers identified from the TCGA-KIRC cohort. (b) Agreement of the two predicted subtypes of renal cancer with AJCC classification in outer KIRC cohort. (c) Kaplan-Meier survival curve of the two predicted subtypes of renal cancer in outer KIRC cohort. (d) Consistency heatmap using Kappa statistics.</div>

Oxidative Medicine and Cellular Longevity

fig8

Figure 8

Figure 8: Establishment of a Prognostic Prediction and Drug Selection Model for Patients with Clear Cell Renal Cell Carcinoma by Multiomics Data Analysis 

Figure 8 | Establishment of a Prognostic Prediction and Drug Selection Model for Patients with Clear Cell Renal Cell Carcinoma by Multiomics Data Analysis 